Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Annovis Bio Stock News

ANVSNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Annovis Bio (ANVS) Forecast

News

Earnings Annovis Bio (ANVS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Annovis Bio Stock News | NYSE:ANVS | Benzinga

Get the latest news on Annovis Bio stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Annovis Bio performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, March 27, 2025

Annovis Bio Receives Notice For Continued Lis...
Benzinga Newsdesk - Mar 27, 2025, 4:32PM

Monday, March 24, 2025

Reported Friday, Annovis Bio Q4 2024 GAAP EPS...
Benzinga Newsdesk - Mar 24, 2025, 2:50AM

Monday, February 10, 2025

Annovis Bio shares are trading lower after D....
Benzinga Newsdesk - Feb 10, 2025, 3:38PM
D. Boral Capital Downgrades Annovis Bio to Ho...
Benzinga Newsdesk - Feb 10, 2025, 7:07AM

Wednesday, February 05, 2025

Annovis Bio Announces That The First Two Pati...
Benzinga Newsdesk - Feb 5, 2025, 8:03AM

Monday, February 03, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Feb 3, 2025, 4:05PM
Annovis Bio shares are trading lower after th...
Benzinga Newsdesk - Feb 3, 2025, 8:02AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Feb 3, 2025, 7:05AM
Annovis Bio Prices $21M Public Offering Of 5....
Benzinga Newsdesk - Feb 3, 2025, 6:24AM
Reported Friday, Annovis Bio Proposed Public ...
Benzinga Newsdesk - Feb 3, 2025, 3:18AM

Tuesday, January 14, 2025

Annovis Bio Granted U.S. Patent For Buntaneta...
Benzinga Newsdesk - Jan 14, 2025, 8:04AM

Tuesday, January 07, 2025

Annovis Bio Announces The FDA Has Accepted An...
Benzinga Newsdesk - Jan 7, 2025, 8:03AM

Monday, November 11, 2024

D. Boral Capital Maintains Buy on Annovis Bio...
Benzinga Newsdesk - Nov 11, 2024, 5:06PM
Annovis Bio shares are trading lower after th...
Benzinga Newsdesk - Nov 11, 2024, 1:52PM
Annovis Bio Q3 EPS $(0.97) Misses $(0.38) Est...
Benzinga Newsdesk - Nov 11, 2024, 8:06AM
HC Wainwright & Co. Reiterates Buy on Annovis...
Benzinga Newsdesk - Nov 11, 2024, 7:28AM

Wednesday, October 16, 2024

Annovis Bio shares are trading higher. HC Wai...
Benzinga Newsdesk - Oct 16, 2024, 12:01PM
HC Wainwright & Co. Reiterates Buy on Annovis...
Benzinga Newsdesk - Oct 16, 2024, 7:08AM

Tuesday, October 15, 2024

EF Hutton Maintains Buy on Annovis Bio, Maint...
Benzinga Newsdesk - Oct 15, 2024, 12:38PM
Annovis Bio shares are trading higher after t...
Benzinga Newsdesk - Oct 15, 2024, 9:23AM
FDA Clears Annovis To Begin Pivotal Phase 3 A...
Benzinga Newsdesk - Oct 15, 2024, 8:07AM

Tuesday, October 01, 2024

HC Wainwright & Co. Reiterates Buy on Annovis...
Benzinga Newsdesk - Oct 1, 2024, 7:08AM

Monday, September 30, 2024

Annovis Files Three New Patents For Combinati...
Benzinga Newsdesk - Sep 30, 2024, 8:07AM

Thursday, August 15, 2024

EF Hutton Maintains Buy on Annovis Bio, Maint...
Benzinga Newsdesk - Aug 15, 2024, 4:21PM
Annovis Bio shares are trading higher. The co...
Benzinga Newsdesk - Aug 15, 2024, 10:31AM
HC Wainwright & Co. Reiterates Buy on Annovis...
Benzinga Newsdesk - Aug 15, 2024, 7:39AM
Annovis Bio Q2 2024 GAAP EPS $(0.44) Misses $...
Benzinga Newsdesk - Aug 15, 2024, 7:16AM

Tuesday, August 13, 2024

EF Hutton Initiates Coverage On Annovis Bio w...
Benzinga Newsdesk - Aug 13, 2024, 7:40AM

Thursday, August 08, 2024

Editas Q2 Earnings & Revenues Miss Estimates, Stock Down
Zacks - Aug 8, 2024, 3:59PM

Tuesday, August 06, 2024

Annovis Announces Preclinical Data Demonstrat...
Benzinga Newsdesk - Aug 6, 2024, 8:04AM

Wednesday, July 24, 2024

Annovis Bio Secures U.S. Patent For Treatment...
Benzinga Newsdesk - Jul 24, 2024, 8:07AM

Wednesday, July 17, 2024

HC Wainwright & Co. Reiterates Buy on Annovis...
Benzinga Newsdesk - Jul 17, 2024, 6:35AM

Tuesday, July 16, 2024

Annovis Bio Granted FDA Approval To Transitio...
Benzinga Newsdesk - Jul 16, 2024, 8:00AM

Monday, July 15, 2024

Immutep Up as Combo Therapy Meets Carcinoma Study Goals
Zacks - Jul 15, 2024, 3:57PM

Thursday, July 11, 2024

Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor - Jul 11, 2024, 8:47AM
HC Wainwright & Co. Maintains Buy on Annovis ...
Benzinga Newsdesk - Jul 11, 2024, 7:45AM

Wednesday, July 10, 2024

UniQure Soars on New Huntington's Disease Study Data
Zacks - Jul 10, 2024, 4:01PM
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor - Jul 10, 2024, 1:18PM

Tuesday, July 09, 2024

Annovis Bio Shares Resume Trade
Benzinga Newsdesk - Jul 9, 2024, 9:39AM
Annovis Shares Halted On Circuit Breaker To D...
Benzinga Newsdesk - Jul 9, 2024, 9:35AM

Friday, July 05, 2024

Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor - Jul 5, 2024, 12:59PM

Wednesday, July 03, 2024

Peering Into Annovis Bio's Recent Short Interest
Benzinga Insights - Jul 3, 2024, 3:00PM
What's Going On With Annovis Shares Today?
Nabaparna Bhattacharya - Jul 3, 2024, 7:12AM
Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
Benzinga Neuro - Jul 2, 2024, 11:38PM

Tuesday, July 02, 2024

Annovis Bio Shares Halted On Circuit Breaker ...
Benzinga Newsdesk - Jul 2, 2024, 1:27PM
Rodman & Renshaw Reiterates Buy on Annovis Bi...
Benzinga Newsdesk - Jul 2, 2024, 12:46PM
What's Going With Annovis Bio Shares Tuesday?
Dylan Berman - Jul 2, 2024, 11:48AM
Annovis Bio Announces Phase III Study Results...
Benzinga Newsdesk - Jul 2, 2024, 8:05AM

Friday, June 28, 2024

Merck's New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
Zacks - Jun 28, 2024, 12:34PM

Thursday, June 27, 2024

Novo Nordisk's Hypertension Drug Study Fails to Meet Goal
Zacks - Jun 27, 2024, 2:42PM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved